Emma T. Bowden

2.1k total citations
25 papers, 1.8k citations indexed

About

Emma T. Bowden is a scholar working on Molecular Biology, Cell Biology and Cancer Research. According to data from OpenAlex, Emma T. Bowden has authored 25 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 10 papers in Cell Biology and 7 papers in Cancer Research. Recurrent topics in Emma T. Bowden's work include Fibroblast Growth Factor Research (5 papers), Cell Adhesion Molecules Research (5 papers) and Proteoglycans and glycosaminoglycans research (5 papers). Emma T. Bowden is often cited by papers focused on Fibroblast Growth Factor Research (5 papers), Cell Adhesion Molecules Research (5 papers) and Proteoglycans and glycosaminoglycans research (5 papers). Emma T. Bowden collaborates with scholars based in United States, France and Canada. Emma T. Bowden's co-authors include Susette C. Mueller, Anton Wellstein, Gerald E. Stoica, Peter J. Coopman, D. A. Thomas, Robert I. Glazer, Anna T. Riegel, Angera H. Kuo, Peter D. Burbelo and Michael Tri H. and has published in prestigious journals such as Nature, Journal of Biological Chemistry and PLoS ONE.

In The Last Decade

Emma T. Bowden

22 papers receiving 1.7k citations

Peers

Emma T. Bowden
Corinne Reimer United States
Bradford W. Ozanne United Kingdom
Marta Canel United Kingdom
Bruce E. Elliott Canada
Jill K. Slack‐Davis United States
Kiyoko Yoshioka Japan
Ari Hashimoto Japan
Berit B. Tysnes Norway
Sara Cabodi Italy
Amanda Chan United States
Corinne Reimer United States
Emma T. Bowden
Citations per year, relative to Emma T. Bowden Emma T. Bowden (= 1×) peers Corinne Reimer

Countries citing papers authored by Emma T. Bowden

Since Specialization
Citations

This map shows the geographic impact of Emma T. Bowden's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emma T. Bowden with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emma T. Bowden more than expected).

Fields of papers citing papers by Emma T. Bowden

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emma T. Bowden. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emma T. Bowden. The network helps show where Emma T. Bowden may publish in the future.

Co-authorship network of co-authors of Emma T. Bowden

This figure shows the co-authorship network connecting the top 25 collaborators of Emma T. Bowden. A scholar is included among the top collaborators of Emma T. Bowden based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emma T. Bowden. Emma T. Bowden is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hopkin, Robert J., Jaya Ganesh, Patrick Deegan, et al.. (2023). STAAR, a phase I/II study of isaralgagene civaparvovec (ST-920) gene therapy in adults with Fabry disease: Dose escalation phase results. Molecular Genetics and Metabolism. 138(2). 107152–107152. 2 indexed citations
2.
3.
Eddy, Sean, Mary Ellen Urick, Nickolay A. Khazanov, et al.. (2013). Abstract C256: Expanded clinical opportunities for crizotinib from an analysis of over 5,000 cancer patient exomes.. Molecular Cancer Therapeutics. 12(11_Supplement). C256–C256.
4.
Williams, Paul D., Emma T. Bowden, Santhoshi Bandla, et al.. (2013). Abstract 2897: Discovery and characterization of driver MAPK and PI3K pathway mutations in tumors and association with drug response in cell lines.. Cancer Research. 73(8_Supplement). 2897–2897. 2 indexed citations
5.
Rosenfield, Sonia, Emma T. Bowden, Krissa A. Gibby, et al.. (2012). Pleiotrophin (PTN) Expression and Function and in the Mouse Mammary Gland and Mammary Epithelial Cells. PLoS ONE. 7(10). e47876–e47876. 19 indexed citations
6.
Li, Jiliang, Richard C.A. Sainson, Chern Ein Oon, et al.. (2011). DLL4-Notch Signaling Mediates Tumor Resistance to Anti-VEGF Therapy In Vivo. Cancer Research. 71(18). 6073–6083. 187 indexed citations
7.
Bowden, Emma T., Rebecca Slack, Akira Myoui, et al.. (2006). Co-localization of cortactin and phosphotyrosine identifies active invadopodia in human breast cancer cells. Experimental Cell Research. 312(8). 1240–1253. 152 indexed citations
8.
̃Tassi, E., Ralf T. Henke, Emma T. Bowden, et al.. (2006). Expression of a Fibroblast Growth Factor–Binding Protein during the Development of Adenocarcinoma of the Pancreas and Colon. Cancer Research. 66(2). 1191–1198. 39 indexed citations
9.
McDonnell, Kevin, et al.. (2005). Vascular leakage in chick embryos after expression of a secreted binding protein for fibroblast growth factors. Laboratory Investigation. 85(6). 747–755. 19 indexed citations
10.
Xie, Bin, E. ̃Tassi, Matthew Swift, et al.. (2005). Identification of the Fibroblast Growth Factor (FGF)-interacting Domain in a Secreted FGF-binding Protein by Phage Display. Journal of Biological Chemistry. 281(2). 1137–1144. 33 indexed citations
11.
Alper, Özge & Emma T. Bowden. (2005). Novel Insights Into c-Src. Current Pharmaceutical Design. 11(9). 1119–1130. 37 indexed citations
12.
Bowden, Emma T. & Anna T. Riegel. (2004). Tetracycline-Regulated Expression of Hammerhead Ribozymes In Vivo. Humana Press eBooks. 252. 179–194.
13.
Bowden, Emma T., Gerald E. Stoica, & Anton Wellstein. (2002). Anti-apoptotic Signaling of Pleiotrophin through Its Receptor, Anaplastic Lymphoma Kinase. Journal of Biological Chemistry. 277(39). 35862–35868. 85 indexed citations
14.
Stoica, Gerald E., et al.. (2002). Midkine Binds to Anaplastic Lymphoma Kinase (ALK) and Acts as a Growth Factor for Different Cell Types. Journal of Biological Chemistry. 277(39). 35990–35998. 271 indexed citations
15.
Oberst, Michael D., et al.. (2002). The RhoA-binding protein, Rhophilin-2, Regulates Actin Cytoskeleton Organization. Journal of Biological Chemistry. 277(46). 43924–43932. 70 indexed citations
16.
Bowden, Emma T., Peter J. Coopman, & Susette C. Mueller. (2001). Chapter 29 Invadopodia: Unique methods for measurement of extracellular matrix degradation in vitro. Methods in cell biology. 63. 613–627. 112 indexed citations
17.
Bowden, Emma T., Susette C. Mueller, & Peter J. Coopman. (2000). In Vitro Invasion Assays: Phagocytosis of the Extracellular Matrix. Current Protocols in Cytometry. 12(1). Unit 9.13–Unit 9.13. 3 indexed citations
18.
Coopman, Peter J., Michael Tri H., Emma T. Bowden, et al.. (2000). The Syk tyrosine kinase suppresses malignant growth of human breast cancer cells. Nature. 406(6797). 742–747. 271 indexed citations
19.
20.
Yu, Ming, Emma T. Bowden, Hiroshi Sato, et al.. (1997). Tyrosine phosphorylation mediates ConA-induced membrane type 1-matrix metalloproteinase expression and matrix metalloproteinase-2 activation in MDA-MB-231 human breast carcinoma cells.. PubMed. 57(22). 5028–32. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Corinne Reimer Breakdown of academic impact, for papers by Bradford W. Ozanne Breakdown of academic impact, for papers by Marta Canel Breakdown of academic impact, for papers by Bruce E. Elliott Breakdown of academic impact, for papers by Jill K. Slack‐Davis Breakdown of academic impact, for papers by Kiyoko Yoshioka Breakdown of academic impact, for papers by Ari Hashimoto Breakdown of academic impact, for papers by Berit B. Tysnes Breakdown of academic impact, for papers by Sara Cabodi Breakdown of academic impact, for papers by Amanda Chan
Rankless by CCL
2026